| NCT06325566 | Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain | RECRUITING | PHASE3 | 2024-07-03 | 2027-10 | 2026-10 |
| NCT02652130 | Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD | COMPLETED | PHASE3 | 2015-10-28 | 2018-06-15 | 2018-06-15 |
| NCT02336230 | A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD) | COMPLETED | PHASE3 | 2015-06-04 | 2018-04-09 | 2018-04-09 |
| NCT02412735 | Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back Pain | COMPLETED | PHASE3 | 2015-03-06 | 2021-06-15 | 2020-05-15 |
| NCT02032004 | Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure. | COMPLETED | PHASE3 | 2014-02-14 | 2020-05-29 | 2020-05-29 |
| NCT01854567 | P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies | COMPLETED | PHASE3 | 2013-08 | 2017-05-05 | 2016-09-23 |
| NCT01851070 | A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor | COMPLETED | PHASE2 | 2013-07 | 2017-03 | 2016-05 |
| NCT01843387 | Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy | COMPLETED | PHASE1, PHASE2 | 2013-07 | 2015-09 | 2014-09 |
| NCT01781390 | Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in Myocardial Infarction | COMPLETED | PHASE2 | 2013-03-11 | 2021-04-06 | 2021-04-06 |
| NCT01576328 | Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes | COMPLETED | PHASE1, PHASE2 | 2012-04 | 2015-10 | 2013-10 |
| NCT01290367 | Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain | COMPLETED | PHASE2 | 2011-08 | 2015-07 | 2013-07 |
| NCT01233960 | Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease | COMPLETED | PHASE3 | 2010-11-29 | 2014-09-15 | 2014-09-15 |
| NCT01106417 | Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion | COMPLETED | PHASE1, PHASE2 | 2010-06 | 2013-03 | 2012-05 |
| NCT01097486 | Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy | COMPLETED | PHASE2 | 2010-06 | 2014-07 | 2013-07 |
| NCT00996073 | Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion | COMPLETED | PHASE2 | 2009-09 | 2014-07 | 2012-07 |
| NCT00877903 | Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI) | COMPLETED | PHASE2 | 2009-03-30 | 2016-03-14 | 2011-05-18 |
| NCT01088191 | Safety and Efficacy Study of MSB-CAR001 in Subjects 6 Weeks Post an Anterior Cruciate Ligament Reconstruction | COMPLETED | PHASE1, PHASE2 | 2009-03 | 2014-10 | 2013-11 |
| NCT00810212 | Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion | WITHDRAWN | PHASE1, PHASE2 | 2008-11 | 2011-11 | 2011-11 |
| NCT00721045 | A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure | COMPLETED | PHASE2 | 2008-08 | 2013-07 | 2011-06 |
| NCT00690066 | PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM) | COMPLETED | PHASE2 | 2008-06-11 | 2011-12-19 | 2010-12-12 |
| NCT00702741 | Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy | COMPLETED | PHASE1, PHASE2 | 2008-06 | 2011-09 | 2011-09 |
| NCT00683722 | PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2008-03-20 | 2010-08-24 | 2009-03-09 |
| NCT00562497 | Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD) | COMPLETED | PHASE3 | 2008-01-31 | 2010-05-20 | 2009-07-14 |
| NCT00549913 | Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF) | COMPLETED | PHASE1, PHASE2 | 2007-10 | 2013-09 | 2013-08 |
| NCT00482092 | Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease | COMPLETED | PHASE3 | 2007-09-17 | 2014-09-15 | 2014-09-15 |
| NCT00543374 | Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease | COMPLETED | PHASE3 | 2007-09-17 | 2011-04-28 | 2009-07 |
| NCT00366145 | Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD) | COMPLETED | PHASE3 | 2006-08-17 | 2009-05-28 | 2008-12-26 |
| NCT00294112 | Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease | COMPLETED | PHASE2 | 2006-03-13 | 2006-07-21 | 2006-07-21 |
| NCT00284986 | Safety and Efficacy of Prochymal® for the Salvage of Treatment-Refractory Acute GVHD Patients | COMPLETED | PHASE2 | 2005-11-18 | 2007-02-08 | 2006-04-25 |
| NCT00225095 | A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy | COMPLETED | PHASE1, PHASE2 | 2005-09 | 2008-04 | 2008-04 |
| NCT00136903 | Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD) | COMPLETED | PHASE2 | 2005-04-27 | 2008-07-14 | 2006-07-28 |
| NCT00114452 | Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction | COMPLETED | PHASE1 | 2005-03-22 | 2008-04-24 | 2006-10-04 |
| NCT00081055 | OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies | WITHDRAWN | PHASE2 | | | |